What we believe

As an organization committed to driving change in caring for patients with diabetes and other chronic diseases, we have a responsibility to make Diversity, Equity, Inclusion & Belonging (DEI&B) part of everything we do -- from developing our products to building and supporting our workforce.

Our commitment to DEI&B is in keeping with the Novo Nordisk Way, which calls upon us to do all we can for the patients and communities we serve, including our own Novo Nordisk employees, some of whom are also patients and caregivers.

To innovate, we must be diverse. To enable diversity and thrive, we must have equity. To activate diversity and equity, we must be inclusive. To unlock our potential, we need belonging.

By listening to and learning from one another, we are already making progress on behalf of the 6 million people who use our medicines in the US.

We sponsor several programs helping to improve individual and public health. Learn about our DEI&B contributions below. 

A disproportionate number of minority populations face health inequities. This includes being affected by serious chronic diseases, such as diabetes and obesity. These communities are also at increased risk for developing complications from these diseases.

This is why we have long-standing commitments with the American Diabetes Association and the National Hemophilia Foundation. We strive to support both national and local efforts to educate patients around these chronic conditions. Many of our efforts support minority and underserved communities, including:

Our commitment to ensure diverse representation in our clinical trials is a key priority of our patient-centered business approach.  We have worked diligently to proactively include sites and investigators in our trials that engage with diverse patient populations, while raising awareness of the opportunities for clinical trial partnership and participation.

With a deliberate focus on developing and improving upon our patient-facing materials and resources, and leveraging patient insights, we continuously improve upon our trial design and operational strategies.

We will continue to reinforce a culture of diversity, equity, inclusion and belonging in clinical trials, expanding and evolving our areas of focus to identify and address barriers to clinical trial participation. This includes addressing access issues and health disparities – staying focused on and dedicated to our patients, healthcare professionals and community needs.

Learn about our clinical trials.

Our Supplier Diversity Program helps us identify, contract with and develop strong working relationships with minority owned businesses. We strive to partner with organizations that reflect the patients we serve, while ensuring business continuity and compliance with federal regulations.

We encourage all of our suppliers to show that they share our values by providing meaningful opportunities to small and diverse businesses.

Companies that are certified by a recognized/authorized third party organization or are self-certified, provide a commodity/service that Novo Nordisk purchases and have the capacity to meet our business needs, are invited to  register with us.

Suppliers must complete and attach to their company profile, a Self-Certification Affadavit form, when completing the online registration.

Available for download here: Self-Certification Affadavit

Novo Nordisk has nine Employee Resource Groups (ERGs) that drive our efforts to foster a sense of belonging and build a more diverse, equitable and inclusive workplace.

Open to all, these groups enhance the work experience and professional development for many of our employees. These employee-led efforts help us to retain and recruit a more diverse workforce so we can better serve our patients and communities. 

Learn more about our employee resource groups. 

We stand with the Human Rights Campaign in calling for the passage of the Equality Act, landmark legislation to help guarantee that all Americans have equal rights and live free of discrimination.

Change happens when we make it our responsibility to act.

Our President Doug Langa has joined the growing list of CEOs and Presidents who have signed the CEO ACT!ON for Diversity & Inclusion pledge.

This is the largest CEO-driven business commitment to advance diversity & inclusion within the workplace. Recognizing that change starts at the executive level, nearly 2,000 CEOs and Presidents of the world’s leading companies and business organizations are leveraging their individual and collective voices to advance diversity & inclusion in the workplace.

By signing the pledge, this group of executives acknowledge the opportunity – and responsibility – to play a meaningful role in such an important societal issue.

Learn more about the pledge here. 

We strive to provide employees with an environment where uniqueness is valued and expectations for growth and development are transparent. We believe that diversity, equity, inclusion and belonging strengthens employee engagement and encourages innovation.

This is why we support a work environment where everyone has an opportunity to fully participate in creating business success and individuals are valued for their unique perspectives.

Learn more about working at Novo Nordisk.